FDA NDC Directory · JSON-LD · Markdown
NDC 62037-560 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Labeler / Manufacturer | Actavis Pharma, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA077419 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | POTASSIUM CHLORIDE (750 mg/1) |
| Marketing started | 20080825 |
| Marketing ended | 20261031 |
| Package count | 4 |
Source: openFDA. Public-domain (CC0).